{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
mafodotin
to a specific field?
Status:
Investigational
Source:
NCT01015911: Phase 1 Interventional Completed Carcinoma, Renal Cell
(2009)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04227847: Phase 1 Interventional Recruiting Myelodysplastic Syndrome
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02213289: Phase 2 Interventional Completed Adenocarcinoma
(2015)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
BLA761158
(2020)
Source URL:
First approved in 2020
Source:
BLA761158
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01891669: Phase 1 Interventional Terminated Neoplasms
(2013)
Source URL:
Class:
CONCEPT
Status:
Other
Class:
CONCEPT
